Jones Financial Companies
GPCR icon

Jones Financial Companies’s Structure Therapeutics GPCR Stock Holding History

Jones Financial Companies’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.7K Sell
175
-166
-49% -$7.34K ﹤0.01% 3850
2026
Q1 		$15.7K Sell
341
-705
-67% -$48.2K ﹤0.01% 3394
2025
Q4 		$72.7K Buy
1,046
+859
+459% +$35.1K ﹤0.01% 2356
2025
Q3 		$4.67K Sell
187
-580
-76% -$11.6K ﹤0.01% 3381
2025
Q2 		$16.2K Sell
767
-2,379
-76% -$52.3K ﹤0.01% 2687
2025
Q1 		$62.2K Sell
3,146
-1,082
-26% -$26.5K ﹤0.01% 1978
2024
Q4 		$115K Buy
4,228
+971
+30% +$34.5K ﹤0.01% 1578
2024
Q3 		$136K Buy
+3,257
New +$126K ﹤0.01% 1286

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Jones Financial Companies's GPCR Position: Q2 2026 in Review

Jones Financial Companies reduced its Structure Therapeutics (GPCR) stake by 49% in Q2 2026, selling an estimated $7.34K and leaving 175 shares worth $8.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3850.

Jones Financial Companies first reported a position in GPCR in Q3 2024 and has held it in 8 quarters since. The position peaked at $136K in Q3 2024. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Jones Financial Companies held 175 shares of Structure Therapeutics worth $8.7K as of Q2 2026.
  • Jones Financial Companies sold 166 Structure Therapeutics shares in Q2 2026, an estimated $7.34K.
  • Structure Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3850 holding.
  • Jones Financial Companies first reported a position in Structure Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Jones Financial Companies's Structure Therapeutics position peaked at $136K in Q3 2024.
  • 191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.